326 Results
Sort By:
Published on August 28, 2024
Philanthropist couple Gary and Alya Michelson have announced a $120 million gift to establish the California Institute for Immunology and Immunotherapy at UCLA’s new Research Park. The new institute will comprise two research entities each provided with $50 million for their launch. One will focus on the rapid development of…
Published on July 21, 2023
Recludix Pharma has announced a strategic collaboration with Sanofi to develop and commercialize first-in-class oral small molecule STAT6 (signal transducer and activator of transcription 6) inhibitors for patients with immunological and inflammatory diseases. STAT6 is believed to play a key role in multiple dermatological and respiratory diseases. Sanofi will pay $125…
Published on June 20, 2023
Eli Lilly today announced it is buying DICE Therapeutics for $2.4 billion. DICE applies its proprietary DELSCAPE technology platform to develop novel oral therapeutic candidates, including IL-17 inhibitors, to treat chronic autoimmune and inflammatory diseases, which are usually treatment with injectables. Its lead products are DC-806, in Phase II, and…
Published on May 11, 2023
A $100 million gift from Gene Lay, the founder and CEO of antibody and reagents company BioLegend, will establish The Gene Lay Institute of Immunology and Inflammation of Brigham and Women’s Hospital. Other organizations involved with the new institute include Massachusetts General Hospital and Harvard Medical School (HMS). Vijay Kuchroo,…
Published on June 2, 2022
Endpoint Health, which specializes in the discovery and development of immune-mediated acute and chronic disease therapeutics announced today it has raised $52 million in a debt and equity financing which will be used to extend the company’s Precision-First platform and expand its therapeutic pipeline. Major investors in the Series A…
Published on August 21, 2018
Caprion Biosciences said today it has acquired Primity Bio for an undisclosed price, in a deal designed to expand the buyer’s immunology and molecular profiling service offering, as well as its ability to support its clients worldwide. Based in Fremont, CA, Primity is a provider of flow cytometry services with…
Published on September 18, 2024
Researchers from the RIKEN Center for Integrative Medical Sciences (IMS) in Japan have discovered that food proteins, typically associated with allergic reactions, can help suppress tumor growth in the small intestine. The study, published in Frontiers in Immunology, shows how these proteins trigger the immune system to prevent the formation…
Published on September 6, 2024
A new study from researchers at the Icahn School of Medicine at Mount Sinai has uncovered critical insights into why aging is the most significant risk factor for cancer. The research, published in Science, details how the aging immune system contributes to tumor growth and offers potential new avenues for…
Published on August 29, 2024
A new study by researchers from the Gladstone Institutes and collaborators shows that the blood coagulation protein fibrin is the culprit that causes the unusual clotting and inflammation that are the primary symptoms of COVID-19. The discovery upends the prevailing view that blood clotting is a consequence of the inflammation…
Published on August 28, 2024
A better way of estimating biological age may be available through an overlooked source. According to researchers at Weill Cornell Medicine and TruDiagnostic, retroelements can act as highly accurate epigenetic clocks predicting chronological age. They used a machine learning model to analyze epigenetic data from over 12,000 individuals of various…
Published on August 26, 2024
A new study will test microbiome biotech BiomeSense’s at-home gut microbiome monitoring technology in a collaboration with probiotic developer Pendulum Therapeutics. The study is small, but BiomeSense’s GutLab technology will allow regular gut microbiome monitoring in the participants’ homes, something that could allow a precision medicine approach to microbiome monitoring…
Published on August 23, 2024
A new study comprehensively maps tumor genes that are self editing to avoid immune attack, providing a roadmap for designing better immunotherapies. A team of researchers found that late tumors used gene editing to suppress antitumor immunity genes, reducing infiltrating immune cells and tumor–immune cell communications. Further, the team found…
Published on August 12, 2024
When it comes to studying and treating cancer, scientists and clinicians often think of applying two key areas of knowledge: the immune system and genomics. The combination of those fields—immunogenomics—is not quite a new field, but it is on the rise. Even in 2015, Robert Holt, PhD, scientific co-director of…
Published on August 12, 2024
There is a team readily available to report 24/7 to a facility at the University of Chicago Medical Center to quickly receive and process a deceased donor’s pancreas into isolated islets for infusion into a patient with type 1 diabetes. The results have been astounding. Some patients who underwent allogeneic…
Published on August 8, 2024
Researchers at the Radboudumc Amalia Children’s Hospital and UMC Utrecht Wilhelmina Children’s Hospital, in the Netherlands, report they have developed a saliva test to indicate the severity of recurrent respiratory infections in children that outperforms the standard blood test. Reporting in the European Respiratory Journal, the investigators noted that if…